Dendritic cells are primary target in new HIV vaccine trial @RockefellerUniv
Dendritic cells are primary target in new HIV vaccine trial  @RockefellerUniv
Uploaded July 2010 | Updated September 2026, 2 hours ago
HIV has been able to outmaneuver every vaccine that's been tried on the virus since it was first discovered in 1981. But no vaccine has yet to directly employ what is arguably the most powerful weapon the human immune system, the dendritic cells that orchestrate the body's response to infection. Now that's about to change. Researchers at Rockefeller University, where dendritic cells were discovered in 1973, are building on decades worth of research to launch a novel vaccine trial in hopes of mustering an immune response strong enough to defeat the deadly virus. It's the first clinical trial of a dendritic cell based vaccine against infection, and researchers hope it will mark a turning point in the battle against AIDS.

http://www.rockefeller.edu
Dendritic cells are primary target in new HIV vaccine trialThe Rockefeller Scientist - Paul Cohen, M.D., Ph.D.The Rockefeller Scientist - Vincent A. Fischetti, Ph.D.Timelapse: The second module for Rockefellers new river campus lifted into place over FDRTimelapse: Concrete is poured for Rockefellers new river campusThe COVID-19 Pandemic: Insights and OverviewThe Rockefeller Scientist: Elizabeth Campbell, Ph.D.A COVID-19 Update: Vaccines and VariantsThe New York Structural Biology CenterThe COVID-19 Pandemic:  Insights and OverviewThe Rockefeller Scientist - Vanessa Ruta, Ph.D.Hardwired for Song and Dance: The Neurobiology of Language and Movement
The Rockefeller University |

Dendritic cells are primary target in new HIV vaccine trial

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER